Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
3151
DELISTED
Rubius Therapeutics, Inc
RUBY
| $540K | ﹤0.01% |
55,747
+35,566
| +176% | +$493K |
|
3152
Regional Management Corp
RM
$301M
| $535K | ﹤0.01% |
9,315
+6,053
| +186% | +$346K |
|
3153
First Bank
FRBA
$464M
| $533K | ﹤0.01% |
36,773
+12,548
| +52% | +$186K |
|
3154
Rhythm Pharmaceuticals
RYTM
$6.81B
| $533K | ﹤0.01% |
53,469
+18,175
| +51% | +$204K |
|
3155
Tidewater
TDW
$3.73B
| $533K | ﹤0.01% |
49,822
+32,779
| +192% | +$385K |
|
3156
Hyster-Yale Materials Handling
HY
$599M
| $532K | ﹤0.01% |
12,961
+7,293
| +129% | +$318K |
|
3157
IES Holdings
IESC
$14.8B
| $532K | ﹤0.01% |
10,511
+6,292
| +149% | +$315K |
|
|
RDUS
3158
DELISTED
Radius Health, Inc.
RDUS
| $532K | ﹤0.01% |
76,823
+19,923
| +35% | +$292K |
|
3159
First Internet Bancorp
INBK
$257M
| $531K | ﹤0.01% |
11,287
+1,510
| +15% | +$61.1K |
|
3160
Marcus Corp
MCS
$894M
| $531K | ﹤0.01% |
29,727
-674
| -2% | -$12.6K |
|
3161
Purple Innovation
PRPL
$35.3M
| $531K | ﹤0.01% |
1,600
+1,560
| +3,900% | +$604K |
|
|
SPNE
3162
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $525K | ﹤0.01% |
38,540
+25,564
| +197% | +$367K |
|
3163
Daily Journal
DJCO
$809M
| $524K | ﹤0.01% |
1,469
+975
| +197% | +$344K |
|
3164
PUT
Sarepta Therapeutics
SRPT
$1.57B
| $522K | ﹤0.01% |
5,800
| – | – |
|
3165
WisdomTree India Earnings Fund ETF
EPI
$2.06B
| $521K | ﹤0.01% |
14,289
-151,207
| -91% | -$5.65M |
|
3166
Oppenheimer Holdings
OPY
$1.14B
| $520K | ﹤0.01% |
11,212
+7,438
| +197% | +$367K |
|
|
RYZ
3167
Ryerson Holding Corp
RYZ
$1.44B
| $520K | ﹤0.01% |
19,945
+12,483
| +167% | +$314K |
|
3168
Axogen
AXGN
$2.27B
| $519K | ﹤0.01% |
55,398
+28,310
| +105% | +$340K |
|
|
NIU
3169
Niu Technologies
NIU
$203M
| $519K | ﹤0.01% |
32,245
-15,417
| -32% | -$340K |
|
3170
Tredegar Corp
TG
$265M
| $519K | ﹤0.01% |
43,895
+22,449
| +105% | +$271K |
|
3171
Astronics
ATRO
$3.43B
| $518K | ﹤0.01% |
51,853
+24,362
| +89% | +$256K |
|
3172
CNB Financial Corp
CCNE
$1.04B
| $517K | ﹤0.01% |
19,518
+12,946
| +197% | +$339K |
|
|
CTT
3173
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $517K | ﹤0.01% |
59,374
+38,254
| +181% | +$341K |
|
|
ITIC
3174
Investors Title Co
ITIC
$546M
| $515K | ﹤0.01% |
2,613
+1,045
| +67% | +$217K |
|
3175
MVB Financial
MVBF
$397M
| $514K | ﹤0.01% |
12,372
+8,241
| +199% | +$348K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.